Invisio AB

IVSO

Equity

ISIN SE0001200015 / Valor 1887072

NASDAQ Nordic Exchange Stockholm, Equities (2025-12-23)

SEK 264.50%

Invisio AB
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Invisio AB is a company specializing in the development and sale of advanced communication and hearing protection systems. These systems are designed to facilitate effective communication for professionals operating in noisy and mission-critical environments, such as military and law enforcement personnel. By integrating hearing protection with communication capabilities, Invisio's products ensure that users can maintain situational awareness and operational effectiveness while safeguarding their hearing. The company's offerings are particularly valuable in settings where clear communication is essential despite high levels of ambient noise.

Summarized from source with an LLMView SourceSector: Telecommunications

Revenue & orders

Q4 2024 revenue: SEK 594.1m (Q4 2023: 345.8). Q4 order intake: SEK 549.3m (298.0). Full‑year revenue: SEK 1,806.7m (1,238.5). Full‑year order intake: SEK 1,970.7m (1,273.5); excluding the third‑party radio order the full‑year order intake was SEK 1,729.8m. Order book at year‑end: SEK 830.8m (602.8).

Profitability

Q4 gross margin: 60.4% (57.4). Q4 EBITDA: SEK 210.1m (84.6), EBITDA margin 35.4%. Q4 operating profit (EBIT): SEK 194.8m (62.4) and operating margin 32.8% (18.0). Full‑year operating profit: SEK 402.3m (242.9), operating margin 22.3%.

Earnings

Q4 profit for the period: SEK 157.7m (50.9). Q4 earnings per share: SEK 3.46 (1.12). Full‑year profit: SEK 306.4m (178.4); full‑year EPS: SEK 6.72 (3.91).

Cash, balance sheet & cash flow

Cash and cash equivalents at year‑end: SEK 242.4m (224.9). Equity: SEK 1,029.0m (720.4) — equity/assets ratio 72% (68). Cash flow from operating activities Q4: SEK 22.9m; full year: SEK 157.0m. Capitalized development costs and investments increased (capitalized dev. costs full year SEK 57.8m), and D&A Q4: SEK 15.3m (full year 61.1m).

Strategic events

Early 2025 acquisition: UltraLynx™ product line (to strengthen tactical body‑worn systems and expected to be revenue enhancing from 2026). Collaboration with the US Defense Innovation Unit on INVISIO Link yielded an initial test order of USD 3.5m in Q4. Company updated addressable market estimate to ~SEK 25bn annually.

Outlook & 2025 considerations

Management expects continued strong demand driven by European defence spending and the enlarged product offering. Several large projects will reach final stages in 2025, which will increase depreciation/amortization and operating expenses tied to R&D and testing; UltraLynx™ is expected to start contributing to revenue from 2026.

Shareholder returns & corporate items

The board proposes a dividend of SEK 2.30 per share for 2024 (prior year 1.30). Number of shares outstanding: 45,590k. INVISIO reiterates targets of ~20% average annual sales growth and >15% operating margin over time.

Summarized from source with an LLMView Source

Key figures

-4.17%1Y

61.1%3Y

10.2%5Y

Performance

39.0%1Y

36.9%3Y

41.2%5Y

Volatility